597 related articles for article (PubMed ID: 19414887)
1. Improving mental health treatments through comparative effectiveness research.
Wang PS; Ulbricht CM; Schoenbaum M
Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
[TBL] [Abstract][Full Text] [Related]
2. Trends in mental health cost growth: an expanded role for management?
Frank RG; Goldman HH; McGuire TG
Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
[TBL] [Abstract][Full Text] [Related]
3. Implementing effectiveness research and improving care for schizophrenia in real-world settings.
Buckley PF; Miller A; Chiles JA; Sajatovic M
Am J Manag Care; 1999 Jun; 5 Spec No():SP47-56. PubMed ID: 10538860
[TBL] [Abstract][Full Text] [Related]
4. What explains the diffusion of treatments for mental illness?
Drake R; Skinner J; Goldman HH
Am J Psychiatry; 2008 Nov; 165(11):1385-92. PubMed ID: 18981070
[No Abstract] [Full Text] [Related]
5. Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.
Neumann PJ
J Clin Psychiatry; 1999; 60 Suppl 3():9-14; discussion 15. PubMed ID: 10073371
[TBL] [Abstract][Full Text] [Related]
6. Impact of drug treatment history on comparative effectiveness research in schizophrenia.
McCombs J; Zolfaghari S; Ganapathy V
Value Health; 2011; 14(5):679-86. PubMed ID: 21839406
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceuticals & psychotropic drugs.
Health Aff (Millwood); 2009; 28(3):723. PubMed ID: 19414880
[No Abstract] [Full Text] [Related]
8. Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice.
Lagomasino IT; Dwight-Johnson M; Simpson GM
Psychiatr Serv; 2005 Jun; 56(6):649-51. PubMed ID: 15939939
[No Abstract] [Full Text] [Related]
9. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
Docherty JP; Browne RA; Farmer M
Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
[TBL] [Abstract][Full Text] [Related]
10. [New psychotropic drugs--is only the price new?].
Woggon B
Praxis (Bern 1994); 1999 Apr; 88(18):819-25. PubMed ID: 10409880
[TBL] [Abstract][Full Text] [Related]
11. Cost of treating mental illness from a managed care perspective.
Docherty JP
J Clin Psychiatry; 1999; 60 Suppl 3():49-52; discussion 53. PubMed ID: 10073378
[TBL] [Abstract][Full Text] [Related]
12. [Off-label applications (professional rationales, financial possibilities)].
László P
Neuropsychopharmacol Hung; 2007 Oct; 9(3):111-2. PubMed ID: 18399028
[No Abstract] [Full Text] [Related]
13. Pharmacoeconomics of schizophrenia in the 21st century.
Hanson MA
J Clin Psychiatry; 1999; 60 Suppl 1():26-7; discussion 28-30. PubMed ID: 10037168
[TBL] [Abstract][Full Text] [Related]
14. Stepped care: doing more with less?
Davison GC
J Consult Clin Psychol; 2000 Aug; 68(4):580-5. PubMed ID: 10965633
[TBL] [Abstract][Full Text] [Related]
15. Methodological challenges in psychiatric treatment adherence research.
Velligan D; Sajatovic M; Valenstein M; Riley WT; Safren S; Lewis-Fernandez R; Weiden P; Ogedegbe G; Jamison J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):74-91. PubMed ID: 20643631
[TBL] [Abstract][Full Text] [Related]
16. Formulary decisions and health economics.
Glazer WM
J Clin Psychiatry; 1998; 59 Suppl 19():23-9. PubMed ID: 9847049
[TBL] [Abstract][Full Text] [Related]
17. Treatment of schizophrenia: let's talk dollars and sense.
Buckley PF
Am J Manag Care; 1998 Mar; 4(3):369-83. PubMed ID: 10178499
[TBL] [Abstract][Full Text] [Related]
18. [Evidence data and importance of public health of the new antipsychotics].
Launois R
Encephale; 2006 Oct; 32(5 Pt 3):S861-5. PubMed ID: 17119488
[No Abstract] [Full Text] [Related]
19. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
Morden NE; Garrison LP
Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
[TBL] [Abstract][Full Text] [Related]
20. An outcomes-based approach to decisions about drug coverage policies in British Columbia.
Morgan S; Bassett K; Mintzes B
Psychiatr Serv; 2004 Nov; 55(11):1230-2. PubMed ID: 15534010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
